Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective ropivacaine dose for labor analgesia with DPE vs standard epidural
ChiCTR2500113306Phase 4Not yet recruiting
- Sponsor
- Affiliated Women and Children's Hospital of Ningbo University
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in labor pain (2 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoints: Effective analgesia at 30 minutes and ED90 of ropivacaine for labor analgesia initiation. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2500113306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113306.